X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA TORRENT PHARMA ALEMBIC PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 29.3 28.4 103.0% View Chart
P/BV x 6.7 5.4 123.7% View Chart
Dividend Yield % 0.7 1.0 69.9%  

Financials

 ALEMBIC PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
TORRENT PHARMA
Mar-17
ALEMBIC PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs7921,768 44.8%   
Low Rs4431,186 37.4%   
Sales per share (Unadj.) Rs167.0346.1 48.3%  
Earnings per share (Unadj.) Rs38.255.2 69.2%  
Cash flow per share (Unadj.) Rs42.073.3 57.3%  
Dividends per share (Unadj.) Rs4.0014.00 28.6%  
Dividend yield (eoy) %0.60.9 68.3%  
Book value per share (Unadj.) Rs84.9257.1 33.0%  
Shares outstanding (eoy) m188.52169.22 111.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.74.3 86.6%   
Avg P/E ratio x16.226.8 60.4%  
P/CF ratio (eoy) x14.720.1 73.0%  
Price / Book Value ratio x7.35.7 126.6%  
Dividend payout %10.525.4 41.3%   
Avg Mkt Cap Rs m116,383249,887 46.6%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m4,2149,934 42.4%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m31,48758,569 53.8%  
Other income Rs m552,233 2.5%   
Total revenues Rs m31,54260,802 51.9%   
Gross profit Rs m10,06013,773 73.0%  
Depreciation Rs m7223,069 23.5%   
Interest Rs m372,056 1.8%   
Profit before tax Rs m9,35610,881 86.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1601,545 139.8%   
Profit after tax Rs m7,1949,336 77.1%  
Gross profit margin %31.923.5 135.9%  
Effective tax rate %23.114.2 162.6%   
Net profit margin %22.815.9 143.3%  
BALANCE SHEET DATA
Current assets Rs m15,06653,841 28.0%   
Current liabilities Rs m7,67431,612 24.3%   
Net working cap to sales %23.538.0 61.8%  
Current ratio x2.01.7 115.3%  
Inventory Days Days6797 68.9%  
Debtors Days Days4184 48.5%  
Net fixed assets Rs m8,23742,079 19.6%   
Share capital Rs m377846 44.6%   
"Free" reserves Rs m15,41642,655 36.1%   
Net worth Rs m16,00543,501 36.8%   
Long term debt Rs m022,408 0.0%   
Total assets Rs m24,594101,250 24.3%  
Interest coverage x255.26.3 4,055.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.6 221.3%   
Return on assets %29.411.3 261.3%  
Return on equity %44.921.5 209.4%  
Return on capital %58.719.6 298.9%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283NA-   
Fx inflow Rs m17,81120,066 88.8%   
Fx outflow Rs m5,3185,304 100.3%   
Net fx Rs m12,49314,762 84.6%   
CASH FLOW
From Operations Rs m9,30410,127 91.9%  
From Investments Rs m-3,105-7,869 39.5%  
From Financial Activity Rs m-1,959-1,918 102.1%  
Net Cashflow Rs m4,240212 2,004.7%  

Share Holding

Indian Promoters % 74.1 71.5 103.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 7.0 41.3%  
FIIs % 9.1 12.6 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 8.8 158.0%  
Shareholders   49,328 26,511 186.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and consumer durables sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 20, 2018 12:01 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS